Pros and cons that are common to all big pharma - Avis employé Employé (anonyme) Merck

3,0
25 août 2010
Employé (anonyme)
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Scientific excellence truly is encouraged, and there is a support network to continue to learn...if you are chosen. In addition, publishing is also encouraged. The people are good to work with in general, and the benefits are good.

Inconvénients

The company is so large, there are many layers of management, and communication between decision makers, and those "in the trenches" who are affected by decisions is virtually non-existant. Large committees make decisions, rather than empowering individuals intimate with the projects to make decisions.

Découvrez plus d’avis sur Merck

5,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Excellent company to work with.

Inconvénients

No cons encountered so far

4,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Inconvénients

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Voir les avis par: Utile|Évaluation|Date|Tout